Skip to main content
. 2020 Aug 11;479(3):493–502. doi: 10.1097/CORR.0000000000001438

Table 1.

Baseline demographic and clinical characteristics of the study population pre-ACA, pre-Medicaid expansion, and post-Medicaid expansion (n = 15,287)

Category Post-ACA
Pre-ACA (2007 to 2010) Pre-Medicaid expansion (2011 to 2013) Post-Medicaid expansion (2014 to 2015) p value
Number of new diagnoses 43% (6537) 33% (5076) 24% (3674)
Age in years, median (interquartile range) 56 (42 to 70) 57 (42 to 69) 57 (42 to 69) 0.441a
Gender 0.01
 Women 46% (3009) 43% (2201) 44% (1620)
 Men 54% (3528) 57% (2875) 56% (2054)
Race 0.007
 White 80% (5230) 80% (4080) 78% (2870)
 Black 11% (749) 11% (551) 12% (428)
 Other 8% (505) 8% (410) 9% (327)
 Unknown 1% (53) 1% (35) 1% (49)
Type of cancer 0.69
 Bones and joints 24% (1582) 24% (1196) 24% (869)
 Soft-tissue sarcoma 76% (4955) 76% (3880) 76% (2805)
Primary site location 0.39
 Upper limb 20% (1276) 20% (989) 21% (756)
 Lower limb 55% (3618) 56% (2849) 56% (2053)
 Pelvis 19% (1264) 18% (932) 18% (662)
 Vertebral column (bone only) 2% (163) 2% (115) 2% (75)
 Other/unspecified 3% (216) 4% (191) 4% (128)
Insurance status < 0.001
 Medicaid 11% (701) 12% (583) 14% (512)
 Private/Medicare/other government 85% (5553) 84% (4262) 83% (3056)
 Uninsured 4% (283) 5% (231) 3% (106)
AJCC stage < 0.001
 I 28% (1809) 38% (1915) 38% (1404)
 II 16% (1069) 20% (1022 23% (860)
 III 14% (938) 21% (1059) 20% (753)
 IV 13% (878) 12% (620) 10% (378)
 Unknown/not applicable 28% (1843) 9% (460) 8% (279)
a

Kruskall-Wallis test; ACA = Affordable Care Act; AJCC = American Joint Commission on Cancer.